Comera Life Sciences Holdings, Inc.

EDGAR

Market value is not computed: no listed ticker is recorded for this company.

25 filing records in this dataset, filed from 2022-03-09 to 2024-02-15. Reported financial figures are available; chart coverage varies by period.

Watchlist

Holdings and insider activity

Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, over the last 12 months.

This issuer has insider filings in the store, but no transaction in this window or code group.

Institutional holders (Form 13F)

Trades by members of Congress

See all insider transactions

Latest quarter

Revenue

136 thousand USD

2023 Q3 · USD

Exact inputs and evidence

Operating margin

-1,582.47%

2023 Q3 · %

Exact inputs and evidence
  • Operating Income: -2157071 USD Source
  • Revenue: 136310 USD Source

Operating cash flow

-1.91 million USD

2023 Q3 · USD

Exact inputs and evidence
  • Operating Cash Flow: -4813299 USD Source
  • Operating Cash Flow: -2899271 USD Source

Free cash flow

-1.91 million USD

2023 Q3 · USD

Exact inputs and evidence
  • Operating Cash Flow: -4813299 USD Source
  • Operating Cash Flow: -2899271 USD Source
  • Capital Expenditure: 94009 USD Source
  • Capital Expenditure: 94009 USD Source
Cash and cash equivalents
1.77 million USD Source
Exact value

1767870 USD

Long-term debt including current maturities
Not available
Shares outstanding
30.7 million shares Source
Exact value

30737796 shares

Reported share-count change

84.57% · 14.1 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence
  • 16653466 shares · 2022-09-30· Source
  • 30737796 shares · 2023-09-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

1 million USD

2022-10-01 – 2023-09-30

Exact inputs and evidence
  • Revenue: 633102 USD · 2022-01-01 – 2022-12-31 Source
  • Revenue: 476982 USD · 2022-01-01 – 2022-09-30 Source
  • Revenue: 392915 USD · 2023-01-01 – 2023-03-31 Source
  • Revenue: 315055 USD · 2023-04-01 – 2023-06-30 Source
  • Revenue: 136310 USD · 2023-07-01 – 2023-09-30 Source

Operating cash flow

-6.66 million USD

2022-10-01 – 2023-09-30

Exact inputs and evidence
  • Operating cash flow: -9771770 USD · 2022-01-01 – 2022-12-31 Source
  • Operating cash flow: -7924004 USD · 2022-01-01 – 2022-09-30 Source
  • Operating cash flow: -1905768 USD · 2023-01-01 – 2023-03-31 Source
  • Operating cash flow: -2899271 USD · 2023-01-01 – 2023-06-30 Source
  • Operating cash flow: -1905768 USD · 2023-01-01 – 2023-03-31 Source
  • Operating cash flow: -4813299 USD · 2023-01-01 – 2023-09-30 Source
  • Operating cash flow: -2899271 USD · 2023-01-01 – 2023-06-30 Source

Capital expenditure

94 thousand USD

2022-10-01 – 2023-09-30

Exact inputs and evidence
  • Capital expenditure: 28607 USD · 2022-01-01 – 2022-12-31 Source
  • Capital expenditure: 28607 USD · 2022-01-01 – 2022-09-30 Source
  • Capital expenditure: 88359 USD · 2023-01-01 – 2023-03-31 Source
  • Capital expenditure: 94009 USD · 2023-01-01 – 2023-06-30 Source
  • Capital expenditure: 88359 USD · 2023-01-01 – 2023-03-31 Source
  • Capital expenditure: 94009 USD · 2023-01-01 – 2023-09-30 Source
  • Capital expenditure: 94009 USD · 2023-01-01 – 2023-06-30 Source

Free cash flow

-6.76 million USD

2022-10-01 – 2023-09-30

Exact inputs and evidence
  • Operating cash flow: -9771770 USD · 2022-01-01 – 2022-12-31 Source
  • Operating cash flow: -7924004 USD · 2022-01-01 – 2022-09-30 Source
  • Operating cash flow: -1905768 USD · 2023-01-01 – 2023-03-31 Source
  • Operating cash flow: -2899271 USD · 2023-01-01 – 2023-06-30 Source
  • Operating cash flow: -1905768 USD · 2023-01-01 – 2023-03-31 Source
  • Operating cash flow: -4813299 USD · 2023-01-01 – 2023-09-30 Source
  • Operating cash flow: -2899271 USD · 2023-01-01 – 2023-06-30 Source
  • Capital expenditure: 28607 USD · 2022-01-01 – 2022-12-31 Source
  • Capital expenditure: 28607 USD · 2022-01-01 – 2022-09-30 Source
  • Capital expenditure: 88359 USD · 2023-01-01 – 2023-03-31 Source
  • Capital expenditure: 94009 USD · 2023-01-01 – 2023-06-30 Source
  • Capital expenditure: 88359 USD · 2023-01-01 – 2023-03-31 Source
  • Capital expenditure: 94009 USD · 2023-01-01 – 2023-09-30 Source
  • Capital expenditure: 94009 USD · 2023-01-01 – 2023-06-30 Source

Company performance

Up to ten complete financial years · consolidated figures

Latest filing vintage with reviewed corrections applied; these values remain separate from issuer-reported figures. Annual charts exclude incomplete years.

Latest filing recorded: 2024-02-15.

Financial data available through: 2022-12-31.

Coverage by financial measure
  • Revenue: 3 of 11 periods available· newest 2022-12-31
  • Operating income: 3 of 11 periods available· newest 2022-12-31
  • net income: No compatible figures in this window
  • Operating cash flow: 3 of 11 periods available· newest 2022-12-31
  • Capital expenditure: 3 of 11 periods available· newest 2022-12-31
  • Total assets: 3 of 11 periods available· newest 2022-12-31
  • Total liabilities: 3 of 11 periods available· newest 2022-12-31
  • Current assets: 3 of 11 periods available· newest 2022-12-31
  • Current liabilities: 3 of 11 periods available· newest 2022-12-31
  • Cash and cash equivalents: 3 of 11 periods available· newest 2022-12-31
  • long term debt: No compatible figures in this window
  • Shares outstanding: 3 of 11 periods available· newest 2022-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

  • Revenue

    +97.9%

    Prior period

    USD 319,832

    –

    Current period

    USD 633,102

    –

    Exact inputs and evidence

    633102 − 319832 = 313270 USD

    319832 USD · 2021-01-01 – 2021-12-31

    Inspect prior input Prior source

    633102 USD · 2022-01-01 – 2022-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Operating cash flow

    −USD 6.01 million

    Prior period

    −USD 3.76 million

    –

    Current period

    −USD 9.77 million

    –

    Exact inputs and evidence

    -9771770 − -3757949 = -6013821 USD

    -3757949 USD · 2021-01-01 – 2021-12-31

    Inspect prior input Prior source

    -9771770 USD · 2022-01-01 – 2022-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Capital expenditure

    -79.9%

    Prior period

    USD 142,013

    –

    Current period

    USD 28,607

    –

    Exact inputs and evidence

    28607 − 142013 = -113406 USD

    142013 USD · 2021-01-01 – 2021-12-31

    Inspect prior input Prior source

    28607 USD · 2022-01-01 – 2022-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Net income.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2022 2022-01-01 – 2022-12-31

  • Revenue USD 633,102 100% of revenue
  • Cost of revenue USD 210,390 33% of revenue
  • Operating expenses USD 12.39 million 1,957% of revenue
  • Operating income −USD 11.97 million −1,891% of revenue
  • Tax, interest and other Derived Unavailable An input is unavailable.
  • Net income Unavailable An input is unavailable.

Cash

  • Operating cash flow −USD 9.77 million −1,543% of revenue
  • Capital expenditure USD 28,607 4.5% of revenue
  • Free cash flow Derived −USD 9.8 million −1,548% of revenue

Share of revenue by period

  • Net income
  • Tax, interest and other
  • Operating costs
  • 2020 Not shown: operating income or net income is not reported.
  • 2021 Not shown: operating income or net income is not reported.
  • 2022 Not shown: operating income or net income is not reported.
Values and sources
Revenue breakdown by annual reporting period
PeriodRevenueOperating costsOperating incomeTax, interest and otherNet incomeFree cash flowSource
2020 2020-01-01 – 2020-12-31442919 2570439 Derived -2127520 UnavailableUnavailable-1816470 Derived
Source
2021 2021-01-01 – 2021-12-31319832 5855460 Derived -5535628 UnavailableUnavailable-3899962 Derived
Source
2022 2022-01-01 – 2022-12-31633102 12603117 Derived -11970015 UnavailableUnavailable-9800377 Derived
Source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 633.1K 2022
Revenue historyRevenue reported for each complete financial period. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.683.8K512.8K341.9K170.9K0.0202020212022
Values and sources
Revenue values and source evidence
PeriodSeriesValue(USD)Source evidence
2020Revenue442919
2021Revenue319832
2022Revenue633102

Revenue growth

Change in revenue from the same financial period one year earlier.

97.9% 2022
Revenue growth historyChange in revenue from the same financial period one year earlier. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.108%72%35%-1%-38%202020212022
Values and sources
Revenue growth values and source evidence
PeriodSeriesValueSource evidence
2020Year over yearNo prior comparable period
2021Year over year-27.8%
2022Year over year97.9%

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -1,890.7% 2022
Free cash flow margin -1,548% 2022
Profit margins historyOperating income, net income and free cash flow as a share of revenue. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.151%-397%-945%-1,494%-2,042%202020212022
  • Operating margin
  • Net margin
  • Free cash flow margin
Values and sources
Profit margins values and source evidence
PeriodSeriesValueSource evidence
2020Operating margin-480.3%
2021Operating margin-1,730.8%
2022Operating margin-1,890.7%
2020-12-31Net marginNot reported
2021-12-31Net marginNot reported
2022-12-31Net marginNot reported
2020Free cash flow margin-410.1%
2021Free cash flow margin-1,219.4%
2022Free cash flow margin-1,548%

Operating cash flow

Cash generated by the company’s normal business operations.

USD -9.8M 2022
Operating cash flow historyCash generated by the company’s normal business operations. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.781.7K-2.1M-4.9M-7.7M-10.6M202020212022
Values and sources
Operating cash flow values and source evidence
PeriodSeriesValue(USD)Source evidence
2020Operating cash flow-1804104
2021Operating cash flow-3757949
2022Operating cash flow-9771770

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -9.8M 2022
Free cash flow historyOperating cash flow minus capital expenditure for the same period and unit. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.784.0K-2.1M-4.9M-7.7M-10.6M202020212022
Values and sources
Free cash flow values and source evidence
PeriodSeriesValue(USD)Source evidence
2020Free cash flow-1816470
2021Free cash flow-3899962
2022Free cash flow-9800377

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

146.4% 2022
Liabilities to assets historyTotal liabilities as a share of total assets. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.158%119%79%40%0%202020212022
Values and sources
Liabilities to assets values and source evidence
PeriodSeriesValueSource evidence
2020Liabilities / assets72.2%
2021Liabilities / assets16.8%
2022Liabilities / assets146.4%

Current assets to current liabilities

Current assets divided by current liabilities.

0.61× 2022
Current assets to current liabilities historyCurrent assets divided by current liabilities. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.7.01×5.26×3.50×1.75×0.00×202020212022
Values and sources
Current assets to current liabilities values and source evidence
PeriodSeriesValueSource evidence
2020Current assets / current liabilities1.33×
2021Current assets / current liabilities6.49×
2022Current assets / current liabilities0.61×

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
PeriodNet incomeOperating cash flowCapital expenditureFree cash flow
2020 2020-01-01 – 2020-12-31
Unavailable Not reported for this period.
−USD 1.8 million
Exact value

Exact value: -1804104 USD

2020-01-01 – 2020-12-31: -1804104 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 12,366
Exact value

Exact value: 12366 USD

2020-01-01 – 2020-12-31: 12366 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 1.82 million
Calculation and evidence

-1804104 − 12366 USD

Exact free cash flow: -1816470 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2021 2021-01-01 – 2021-12-31
Unavailable Not reported for this period.
−USD 3.76 million
Exact value

Exact value: -3757949 USD

2021-01-01 – 2021-12-31: -3757949 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 142,013
Exact value

Exact value: 142013 USD

2021-01-01 – 2021-12-31: 142013 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 3.9 million
Calculation and evidence

-3757949 − 142013 USD

Exact free cash flow: -3899962 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2022 2022-01-01 – 2022-12-31
Unavailable Not reported for this period.
−USD 9.77 million
Exact value

Exact value: -9771770 USD

2022-01-01 – 2022-12-31: -9771770 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 28,607
Exact value

Exact value: 28607 USD

2022-01-01 – 2022-12-31: 28607 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 9.8 million
Calculation and evidence

-9771770 − 28607 USD

Exact free cash flow: -9800377 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

25 filings · 599 latest values · 599 originally reported values

Dataset published . Source filing dates and reporting periods are shown separately.

Identifiers: 0001907685, 1907685, edgar:1907685

Also known as COMERA LIFE SCIENCES HOLDINGS, INC., Comera Life Sciences Holdings, Inc.